Growth Metrics

Novanta (NOVT) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Novanta (NOVT) over the last 17 years, with Q3 2025 value amounting to $136.9 million.

  • Novanta's Cost of Revenue rose 127.6% to $136.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $530.1 million, marking a year-over-year increase of 335.09%. This contributed to the annual value of $527.7 million for FY2024, which is 953.47% up from last year.
  • Novanta's Cost of Revenue amounted to $136.9 million in Q3 2025, which was up 127.6% from $134.3 million recorded in Q2 2025.
  • Over the past 5 years, Novanta's Cost of Revenue peaked at $136.9 million during Q3 2025, and registered a low of $93.8 million during Q2 2021.
  • For the 5-year period, Novanta's Cost of Revenue averaged around $121.0 million, with its median value being $123.8 million (2022).
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 3618.67% in 2021, then tumbled by 711.94% in 2023.
  • Quarter analysis of 5 years shows Novanta's Cost of Revenue stood at $116.1 million in 2021, then grew by 6.68% to $123.8 million in 2022, then fell by 7.12% to $115.0 million in 2023, then grew by 12.89% to $129.8 million in 2024, then increased by 5.45% to $136.9 million in 2025.
  • Its last three reported values are $136.9 million in Q3 2025, $134.3 million for Q2 2025, and $129.0 million during Q1 2025.